跳至主要内容
临床试验/JPRN-UMIN000023361
JPRN-UMIN000023361已完成未知

A Phase II Study of Short-course Radiotherapy Preoperatively followed by Capecitabine and Oxaliplatin (XELOX) for cT3 Node-positive Lower Rectal Cancer - ADVANCE-RC study

Cancer Institute Hospital of Japanese Foundation for Cancer Research0 个研究点目标入组 28 人开始时间: 2016年8月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
28

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. cT4 or cN2. 2. CRM less than 1mm. 3. Administration contraindication of oxaliplatin or capecitabine. 4. History of the serious hypersensitivity for any agents. 5. History of pelvic irradiation. 6. Uncontrolled active infection. 7. Clinically significant complication (heart failure, interstitial lung disease or pulmonary fibrosis, uncontrolled diabetes, renal failure, liver failure, etc.) 8. Evidence of peripheral sensory neuropathy. 9. Uncontrolled diarrhea. 10. Uncontrolled pleural effusion or ascites. 11. Multiple primary cancer within 5 years. 12. Possible pregnant, pregnant or breast-feeding female. 13. Other conditions not suitable for this study.

研究者

发起方
Cancer Institute Hospital of Japanese Foundation for Cancer Research

相似试验